Shares of Flag Ship Acquisition Corp. (NASDAQ:ETHZ – Free Report) are going to reverse split before the market opens on Monday, October 20th. The 1-10 reverse split was announced on Wednesday, October 15th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, October 17th.
Flag Ship Acquisition Stock Performance
ETHZ stock opened at $1.83 on Thursday. Flag Ship Acquisition has a twelve month low of $0.66 and a twelve month high of $17.75. The company has a market capitalization of $300.91 million, a PE ratio of -0.12 and a beta of 0.38.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Flag Ship Acquisition in a report on Wednesday, October 8th. Wall Street Zen lowered Flag Ship Acquisition to a “strong sell” rating in a report on Saturday, August 30th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.
Flag Ship Acquisition Company Profile
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.
Featured Stories
- Five stocks we like better than Flag Ship Acquisition
- What is a Low P/E Ratio and What Does it Tell Investors?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- The Risks of Owning Bonds
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Dividend Kings To Consider
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Flag Ship Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flag Ship Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.